- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Neuroscience 15 (2021): 666679.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Yakubov, Eduard
Eibl, Thomas
Hammer, Alexander
Holtmannspötter, Markus
Savaskan, Nicolai
Steiner, Hans-Herbert
- DOI
-
10.3389/fnins.2021.666679
- URN
-
urn:nbn:de:bvb:29-opus4-165746
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yakubov, Eduard
- Eibl, Thomas
- Hammer, Alexander
- Holtmannspötter, Markus
- Savaskan, Nicolai
- Steiner, Hans-Herbert
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
Recent advances in the therapeutic applications of selenium nanoparticles
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential
Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Pregnancy, thyroid, and the potential use of selenium
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review
Therapeutic potential of targeting micro RNA ‐10b in established intracranial glioblastoma: first steps toward the clinic
Neurotransmitters: potential targets in glioblastoma
Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells
MTAP loss: a possible therapeutic approach for glioblastoma
Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
Recent advances in the therapeutic applications of selenium nanoparticles
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential
Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Pregnancy, thyroid, and the potential use of selenium
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review
Therapeutic potential of targeting micro RNA ‐10b in established intracranial glioblastoma: first steps toward the clinic
Neurotransmitters: potential targets in glioblastoma
Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells
MTAP loss: a possible therapeutic approach for glioblastoma
Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
Recent advances in the therapeutic applications of selenium nanoparticles
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential
Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Pregnancy, thyroid, and the potential use of selenium
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review
Therapeutic potential of targeting micro RNA ‐10b in established intracranial glioblastoma: first steps toward the clinic
Neurotransmitters: potential targets in glioblastoma
Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells